Commercial strain-derived clinical Saccharomyces cerevisiae can evolve new phenotypes without higher pathogenicity
Scope: Saccharomyces cerevisiae is one of the most important microbes in food industry, but there is growing evidence on its potential pathogenicity as well. Its status as a member of human mycobiome is still not fully understood.Methods and results: In this study, we characterise clinical S. cerevi...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
Wiley
2017
|
| Sorozat: | MOLECULAR NUTRITION & FOOD RESEARCH
61 No. 11 |
| doi: | 10.1002/mnfr.201601099 |
| mtmt: | 3253243 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/12172 |